2016 - Fellow of the Royal Society of Canada Academy of Science
William D. Foulkes spends much of his time researching Breast cancer, Internal medicine, Oncology, Cancer and Cancer research. His research integrates issues of Odds ratio, Gynecology, Ovarian cancer and Risk factor in his study of Breast cancer. William D. Foulkes has included themes like Surgery and PALB2 in his Internal medicine study.
His work deals with themes such as BRCA mutation, Case-control study, Mammary gland, Gene mutation and Hazard ratio, which intersect with Oncology. His Cancer research includes themes of Genetic counseling, Prospective cohort study and Carcinoma. His biological study spans a wide range of topics, including Immunohistochemistry, Pathology, Germline mutation, Phenotype and Tumor suppressor gene.
His primary scientific interests are in Internal medicine, Breast cancer, Oncology, Cancer and Genetics. His studies link Endocrinology with Internal medicine. His Breast cancer research is multidisciplinary, incorporating perspectives in Odds ratio, Cancer research, PALB2, Ovarian cancer and Gynecology.
His Oncology research incorporates elements of Oophorectomy, BRCA mutation, Tamoxifen, Genetic counseling and Prospective cohort study. His Cancer research is multidisciplinary, incorporating elements of Allele and Genetic testing. His Germline research integrates issues from Somatic cell, Small-cell carcinoma and Pathology.
His scientific interests lie mostly in Pathology, Germline, Internal medicine, Cancer and DICER1 Syndrome. His work on Embryonal rhabdomyosarcoma, Neoplasm and Thyroid nodules as part of general Pathology research is often related to In patient, thus linking different fields of science. His Germline study integrates concerns from other disciplines, such as Penetrance, Germline mutation, Somatic cell and Cancer research.
His work deals with themes such as Context and Oncology, which intersect with Internal medicine. His study in Cancer concentrates on Breast cancer and Cancer cell. His Breast cancer research focuses on PALB2 and how it connects with Pancreatic cancer.
William D. Foulkes mostly deals with Germline, Cancer, Breast cancer, Pathology and Germline mutation. His research in Germline intersects with topics in Penetrance, Loss of heterozygosity and Somatic cell. His study in Cancer is interdisciplinary in nature, drawing from both DNA, Cancer research and Oncology.
His research integrates issues of CHEK2, Missense mutation, FANCM and Gene mutation in his study of Breast cancer. The concepts of his Pathology study are interwoven with issues in Nasal Chondromesenchymal Hamartoma, Thyroid carcinoma and DICER1 Syndrome. His research in Internal medicine tackles topics such as PALB2 which are related to areas like Family history, Age of onset, Founder effect and Genetic testing.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Triple-negative breast cancer.
William D. Foulkes;Ian E. Smith;Jorge S. Reis-Filho.
The New England Journal of Medicine (2010)
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies
Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks.
PLOS Medicine (2010)
Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
William D. Foulkes;Ingunn M. Stefansson;Pierre O. Chappuis;Louis R. Bégin.
Journal of the National Cancer Institute (2004)
BRCA1 and BRCA2 : 1994 and beyond
Steven A. Narod;William D. Foulkes.
Nature Reviews Cancer (2004)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale.
The New England Journal of Medicine (2014)
Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results
Sharon E. Plon;Diana M. Eccles;Douglas Easton;William D. Foulkes.
Human Mutation (2008)
Familial Adenomatous Polyposis
Polymnia Galiatsatos;William D Foulkes.
The American Journal of Gastroenterology (2006)
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Douglas Frederick Easton;Paul David Pharoah;Antonis C. Antoniou;Marc Derek Tischkowitz.
The New England Journal of Medicine (2015)
Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Kelly Metcalfe;Henry T. Lynch;Parviz Ghadirian;Nadine Tung.
Journal of Clinical Oncology (2004)
Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 Mutation
Amy Finch;Mario Beiner;Jan Lubinski;Henry T. Lynch.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: